Proton therapy used to be an area of niche research and a very expensive way to treat cancer. It is now increasingly moving into the mainstream, and becoming a key part of the arsenal to fight cancer.
|
Our global survey of 1,000 issuers and 1,000 investors reveals that sustainable investing is becoming mainstream and shows how the effects of COVID-19 are changing attitudes amongst market participants.